273 related articles for article (PubMed ID: 28546357)
1. Gut Microbiota: Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension.
Qi Y; Kim S; Richards EM; Raizada MK; Pepine CJ
Circ Res; 2017 May; 120(11):1724-1726. PubMed ID: 28546357
[TBL] [Abstract][Full Text] [Related]
2. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
[TBL] [Abstract][Full Text] [Related]
3. Microbiome and hypertension: where are we now?
Vallianou NG; Geladari E; Kounatidis D
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):83-88. PubMed ID: 31809283
[TBL] [Abstract][Full Text] [Related]
4. [INTESTINAL MICROBIOTA: ITS ROLE IN PATHOGENESIS OF ARTERIAL HYPERTENSION].
Aitbaev KA; Murkamilov IE
Klin Med (Mosk); 2017; 95(2):123-6. PubMed ID: 30303663
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies.
Kang Y; Cai Y
Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):110-117. PubMed ID: 29102544
[TBL] [Abstract][Full Text] [Related]
6. Current Perspectives on Antihypertensive Probiotics.
Daliri EB; Lee BH; Oh DH
Probiotics Antimicrob Proteins; 2017 Jun; 9(2):91-101. PubMed ID: 27900619
[TBL] [Abstract][Full Text] [Related]
7. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
[TBL] [Abstract][Full Text] [Related]
8. Altered Gut Microbiota is Involved in the Anti-Hypertensive Effects of Vitamin C in Spontaneously Hypertensive Rat.
Li Y; Salih Ibrahim RM; Chi HL; Xiao T; Xia WJ; Li HB; Kang YM
Mol Nutr Food Res; 2021 Apr; 65(7):e2000885. PubMed ID: 33547879
[TBL] [Abstract][Full Text] [Related]
9. Probiotics in digestive, emotional, and pain-related disorders.
Roman P; Abalo R; Marco EM; Cardona D
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):103-119. PubMed ID: 29521671
[TBL] [Abstract][Full Text] [Related]
10. Untapped potential of gut microbiome for hypertension management.
Gao K; Wang PX; Mei X; Yang T; Yu K
Gut Microbes; 2024; 16(1):2356278. PubMed ID: 38825779
[TBL] [Abstract][Full Text] [Related]
11. Dietary Additive Probiotics Modulation of the Intestinal Microbiota.
Hu S; Wang L; Jiang Z
Protein Pept Lett; 2017; 24(5):382-387. PubMed ID: 28240160
[TBL] [Abstract][Full Text] [Related]
12. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
Hatton G; Shawcross DL
Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):1-2. PubMed ID: 30791837
[No Abstract] [Full Text] [Related]
13. The gut microbiome.
Sidhu M; van der Poorten D
Aust Fam Physician; 2017; 46(4):206-211. PubMed ID: 28376573
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiota and blood pressure in experimental models.
Jama HA; Kaye DM; Marques FZ
Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):97-104. PubMed ID: 30531472
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
Haak BW; Prescott HC; Wiersinga WJ
Front Immunol; 2018; 9():2042. PubMed ID: 30250472
[TBL] [Abstract][Full Text] [Related]
17. Invited review: Effect of antihypertensive fermented milks on gut microbiota.
Beltrán-Barrientos LM; García HS; Hernández-Mendoza A; González-Córdova AF; Vallejo-Cordoba B
J Dairy Sci; 2021 Apr; 104(4):3779-3788. PubMed ID: 33752288
[TBL] [Abstract][Full Text] [Related]
18. Role of Probiotics in the Management of COVID-19: A Computational Perspective.
Nguyen QV; Chong LC; Hor YY; Lew LC; Rather IA; Choi SB
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057455
[TBL] [Abstract][Full Text] [Related]
19. The gut microbiome and hypertension.
Pevsner-Fischer M; Blacher E; Tatirovsky E; Ben-Dov IZ; Elinav E
Curr Opin Nephrol Hypertens; 2017 Jan; 26(1):1-8. PubMed ID: 27798455
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
